Full-year results for the year to 30 June were in line with the 10 July trading update, with FY 2020 revenues of £1.1m (-55%) with an adjusted pre-tax loss of £6.5m (-18%) and year-end cash of £8.2m (+134%). They reflect a year which brought notable challenges, but also significant opportunities, which genedrive has responded to. While regulatory delays have thus far prevented material revenues from COVID-19 testing, they have the potential to be transformational in FY 2021. GDR confirmed that i ....
17 Nov 2020
genedrive - FY 2020 results and advanced COVID-19 opportunity
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
genedrive - FY 2020 results and advanced COVID-19 opportunity
Genedrive Plc (GDR:LON) | 5.9 0 0.0% | Mkt Cap: 8.41m
- Published:
17 Nov 2020 -
Author:
Mark Brewer | Cavendish Research -
Pages:
12
Full-year results for the year to 30 June were in line with the 10 July trading update, with FY 2020 revenues of £1.1m (-55%) with an adjusted pre-tax loss of £6.5m (-18%) and year-end cash of £8.2m (+134%). They reflect a year which brought notable challenges, but also significant opportunities, which genedrive has responded to. While regulatory delays have thus far prevented material revenues from COVID-19 testing, they have the potential to be transformational in FY 2021. GDR confirmed that i ....